S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 2.29 USD 1.33%
Market Cap: 193.9m USD
Have any thoughts about
Stereotaxis Inc?
Write Note

Stereotaxis Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stereotaxis Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
S
Stereotaxis Inc
AMEX:STXS
Net Issuance of Common Stock
$159k
CAGR 3-Years
-35%
CAGR 5-Years
-63%
CAGR 10-Years
-35%
Becton Dickinson and Co
NYSE:BDX
Net Issuance of Common Stock
-$500m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Boston Scientific Corp
NYSE:BSX
Net Issuance of Common Stock
$219m
CAGR 3-Years
N/A
CAGR 5-Years
13%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Net Issuance of Common Stock
-$253m
CAGR 3-Years
42%
CAGR 5-Years
-100%
CAGR 10-Years
17%
Intuitive Surgical Inc
NASDAQ:ISRG
Net Issuance of Common Stock
$345.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stereotaxis Inc
Glance View

Market Cap
194m USD
Industry
Health Care

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.

STXS Intrinsic Value
1.41 USD
Overvaluation 39%
Intrinsic Value
Price
S

See Also

What is Stereotaxis Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
159k USD

Based on the financial report for Sep 30, 2024, Stereotaxis Inc's Net Issuance of Common Stock amounts to 159k USD.

What is Stereotaxis Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-35%

Over the last year, the Net Issuance of Common Stock growth was 33%. The average annual Net Issuance of Common Stock growth rates for Stereotaxis Inc have been -35% over the past three years , -63% over the past five years , and -35% over the past ten years .

Back to Top